{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:27:22Z","timestamp":1787495242585,"version":"build-2736575974"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160464"],"award-info":[{"award-number":["82160464"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20242BAB26146"],"award-info":[{"award-number":["20242BAB26146"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangxi Key Laboratory for Individualized Cancer Therapy","award":["20202BCD42011"],"award-info":[{"award-number":["20202BCD42011"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Currently, research on ferroptosis-related prognostic models for gastric cancer is limited, whereas traditional predictive models often have a narrow perspective and low accuracy. In this study, we systematically analyzed the expression patterns of ferroptosis-related genes in patients with gastric adenocarcinoma and evaluated their prognostic value. Using data from The Cancer Genome Atlas (TCGA) and the FerrDb database, we developed a ferroptosis-related prognostic risk model based on four genes: hydroxycarboxylic acid receptor 1 (HCAR1), branched-chain amino acid transaminase 1 (BCAT1), ceruloplasmin (CP), and dickkopf-1 (DKK1). This model demonstrated strong prognostic value and potential clinical relevance in stratifying gastric cancer patients by overall survival outcomes. ferroptosis-related prognostic risk model. Compared to traditional clinicopathological features, the risk score derived from this model exhibited superior predictive accuracy for overall survival in patients with gastric cancer and served as an independent prognostic factor. Functional enrichment analysis revealed that the risk score was primarily enriched for extracellular matrix-related pathways. Additionally, the risk score was significantly correlated with TME signature genes, immune checkpoint expression, and immune cell infiltration in stomach adenocarcinoma (STAD). Mechanistic studies revealed that HCAR1 is abnormally overexpressed in gastric cancer tissues and is associated with a poor prognosis. It exerted its effects by regulating the GPX4\/SLC7A11 axis to inhibit lipid peroxidation and malondialdehyde accumulation, thereby obstructing ferroptosis. Experimental validation demonstrated that the downregulation of HCAR1 promoted ferroptosis and suppressed malignant tumor phenotypes, suggesting that both the gene and its associated risk model hold significant clinical value as potential therapeutic targets and prognostic biomarkers.<\/jats:p>","DOI":"10.1093\/carcin\/bgaf030","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T07:55:56Z","timestamp":1749110156000},"source":"Crossref","is-referenced-by-count":4,"title":["Identification of HCAR1 as a ferroptosis-related biomarker of gastric cancer based on a novel ferroptosis-related prognostic model and in vitro experiments"],"prefix":"10.1093","volume":"46","author":[{"given":"Hongjiao","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University , 1519 Dongyue Avenue, Nanchang, Jiangxi Province ,","place":["P.R. China"]},{"name":"Jiangxi Key Laboratory for Individualized Cancer Therapy , 17 Yongwai Street, Nanchang 330006, Jiangxi ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Zhan","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University , 1519 Dongyue Avenue, Nanchang, Jiangxi Province ,","place":["P.R. China"]},{"name":"Jiangxi Key Laboratory for Individualized Cancer Therapy , 17 Yongwai Street, Nanchang 330006, Jiangxi ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanjuan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University , 1519 Dongyue Avenue, Nanchang, Jiangxi Province ,","place":["P.R. China"]},{"name":"Jiangxi Key Laboratory for Individualized Cancer Therapy , 17 Yongwai Street, Nanchang 330006, Jiangxi ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University , 1519 Dongyue Avenue, Nanchang, Jiangxi Province ,","place":["P.R. China"]},{"name":"Jiangxi Key Laboratory for Individualized Cancer Therapy , 17 Yongwai Street, Nanchang 330006, Jiangxi ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"He","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University , 1519 Dongyue Avenue, Nanchang, Jiangxi Province ,","place":["P.R. China"]},{"name":"Jiangxi Key Laboratory for Individualized Cancer Therapy , 17 Yongwai Street, Nanchang 330006, Jiangxi ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Le","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University , 1519 Dongyue Avenue, Nanchang, Jiangxi Province ,","place":["P.R. China"]},{"name":"Jiangxi Key Laboratory for Individualized Cancer Therapy , 17 Yongwai Street, Nanchang 330006, Jiangxi ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University , 1519 Dongyue Avenue, Nanchang, Jiangxi Province ,","place":["P.R. China"]},{"name":"Jiangxi Key Laboratory for Individualized Cancer Therapy , 17 Yongwai Street, Nanchang 330006, Jiangxi ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University , 1519 Dongyue Avenue, Nanchang, Jiangxi Province ,","place":["P.R. China"]},{"name":"Jiangxi Key Laboratory for Individualized Cancer Therapy , 17 Yongwai Street, Nanchang 330006, Jiangxi ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Jiangxi Maternal and Child Health Hospital , 318 Bayi Road, Nanchang 330006 ,","place":["PR China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8734-584X","authenticated-orcid":false,"given":"Xiaojun","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University , 1519 Dongyue Avenue, Nanchang, Jiangxi Province ,","place":["P.R. China"]},{"name":"Jiangxi Key Laboratory for Individualized Cancer Therapy , 17 Yongwai Street, Nanchang 330006, Jiangxi ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,7]]},"reference":[{"key":"2025063006161384000_CIT0001","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/ijc.35278","article-title":"The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide","volume":"156","author":"Filho","year":"2025","journal-title":"Int J Cancer"},{"key":"2025063006161384000_CIT0002","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","article-title":"Gastric cancer treatment: recent progress and future perspectives","volume":"16","author":"Guan","year":"2023","journal-title":"J Hematol Oncol"},{"key":"2025063006161384000_CIT0003","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"2025063006161384000_CIT0004","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening horizons: the role of ferroptosis in cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"2025063006161384000_CIT0005","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"2025063006161384000_CIT0006","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.ccell.2018.03.017","article-title":"Multi-stage differentiation defines melanoma subtypes with differential vulnerability to drug-induced iron-dependent oxidative stress","volume":"33","author":"Tsoi","year":"2018","journal-title":"Cancer Cell"},{"key":"2025063006161384000_CIT0007","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41419-023-05868-z","article-title":"HNF4A-BAP31-VDAC1 axis synchronously regulates cell proliferation and ferroptosis in gastric cancer","volume":"14","author":"Zhou","year":"2023","journal-title":"Cell Death Dis"},{"key":"2025063006161384000_CIT0008","doi-asserted-by":"publisher","first-page":"9767","DOI":"10.3390\/ijms23179767","article-title":"The ferroptosis molecular subtype reveals characteristics of the tumor microenvironment, immunotherapeutic response, and prognosis in gastric cancer","volume":"23","author":"Xu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2025063006161384000_CIT0009","doi-asserted-by":"publisher","first-page":"756193","DOI":"10.3389\/fnut.2021.756193","article-title":"Characterization of two ferroptosis subtypes with distinct immune infiltration and gender difference in gastric cancer","volume":"8","author":"Ma","year":"2021","journal-title":"Front Nutr"},{"key":"2025063006161384000_CIT0010","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12013-022-01124-x","article-title":"Ferroptosis-related NFE2L2 and NOX4 genes are potential risk prognostic biomarkers and correlated with immunogenic features in glioma","volume":"81","author":"Lin","year":"2023","journal-title":"Cell Biochem Biophys"},{"key":"2025063006161384000_CIT0011","doi-asserted-by":"publisher","first-page":"5277","DOI":"10.1007\/s00405-022-07433-4","article-title":"Potential ferroptosis-related diagnostic and prognostic biomarkers in laryngeal cancer","volume":"279","author":"Ji","year":"2022","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"2025063006161384000_CIT0012","doi-asserted-by":"publisher","first-page":"833","DOI":"10.21037\/atm-22-3736","article-title":"Comprehensive analysis of the relationship between the ferroptosis and tumor-infiltrating immune cells, mutation, and immunotherapy in breast cancer","volume":"10","author":"He","year":"2022","journal-title":"Ann Transl Med"},{"key":"2025063006161384000_CIT0013","doi-asserted-by":"publisher","first-page":"107370","DOI":"10.1016\/j.compbiomed.2023.107370","article-title":"Analysis of a new therapeutic target and construction of a prognostic model for breast cancer based on ferroptosis genes","volume":"165","author":"Li","year":"2023","journal-title":"Comput Biol Med"},{"key":"2025063006161384000_CIT0014","doi-asserted-by":"publisher","first-page":"783362","DOI":"10.3389\/fimmu.2021.783362","article-title":"Identification and validation of ferroptosis-related LncRNA signatures as a novel prognostic model for colon cancer","volume":"12","author":"Wu","year":"2021","journal-title":"Front Immunol"},{"key":"2025063006161384000_CIT0015","doi-asserted-by":"publisher","first-page":"739470","DOI":"10.3389\/fgene.2021.739470","article-title":"Construction on of a ferroptosis-related lncRNA-based model to improve the prognostic evaluation of gastric cancer patients based on bioinformatics","volume":"12","author":"Pan","year":"2021","journal-title":"Front Genet"},{"key":"2025063006161384000_CIT0016","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat Commun"},{"key":"2025063006161384000_CIT0017","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.1038\/s41388-021-01853-y","article-title":"A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma","volume":"40","author":"Wu","year":"2021","journal-title":"Oncogene"},{"key":"2025063006161384000_CIT0018","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12967-023-04033-6","article-title":"Constructing a novel mitochondrial-related gene signature for evaluating the tumor immune microenvironment and predicting survival in stomach adenocarcinoma","volume":"21","author":"Chang","year":"2023","journal-title":"J Transl Med"},{"key":"2025063006161384000_CIT0019","doi-asserted-by":"publisher","first-page":"22830","DOI":"10.1038\/s41598-023-49832-5","article-title":"Prognostic value of normal levels of preoperative tumor markers in colorectal cancer","volume":"13","author":"Ren","year":"2023","journal-title":"Sci Rep"},{"key":"2025063006161384000_CIT0020","doi-asserted-by":"publisher","first-page":"1235266","DOI":"10.3389\/fimmu.2023.1235266","article-title":"Association between a four-parameter inflammatory index and all-cause mortality in critical ill patients with non-traumatic subarachnoid hemorrhage: a retrospective analysis of the MIMIC-IV database (2012-2019)","volume":"14","author":"Huang","year":"2023","journal-title":"Front Immunol"},{"key":"2025063006161384000_CIT0021","doi-asserted-by":"publisher","first-page":"24768","DOI":"10.18632\/aging.203714","article-title":"Tumor purity as a prognosis and immunotherapy relevant feature in cervical cancer","volume":"13","author":"Deng","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"2025063006161384000_CIT0022","doi-asserted-by":"publisher","first-page":"1197898","DOI":"10.3389\/fonc.2023.1197898","article-title":"Tumor purity-associated genes influence hepatocellular carcinoma prognosis and tumor microenvironment","volume":"13","author":"Zhao","year":"2023","journal-title":"Front Oncol"},{"key":"2025063006161384000_CIT0023","doi-asserted-by":"publisher","first-page":"948647","DOI":"10.3389\/fimmu.2022.948647","article-title":"Recent progress and future perspectives of immunotherapy in advanced gastric cancer","volume":"13","author":"Jin","year":"2022","journal-title":"Front Immunol"},{"key":"2025063006161384000_CIT0024","doi-asserted-by":"publisher","first-page":"108487","DOI":"10.1016\/j.celrep.2020.108487","article-title":"HCAR1\/MCT1 regulates tumor ferroptosis through the lactate-mediated ampk-scd1 activity and its therapeutic implications","volume":"33","author":"Zhao","year":"2020","journal-title":"Cell Rep"},{"key":"2025063006161384000_CIT0025","doi-asserted-by":"publisher","first-page":"110791","DOI":"10.1016\/j.cellsig.2023.110791","article-title":"Curcumin derivative NL01 induces ferroptosis in ovarian cancer cells via HCAR1\/MCT1 signaling","volume":"109","author":"Shi","year":"2023","journal-title":"Cell Signal"},{"key":"2025063006161384000_CIT0026","doi-asserted-by":"publisher","first-page":"e202105043","DOI":"10.1083\/jcb.202105043","article-title":"Mitochondrial regulation of ferroptosis","volume":"220","author":"Gan","year":"2021","journal-title":"J Cell Biol"},{"key":"2025063006161384000_CIT0027","doi-asserted-by":"publisher","first-page":"7038","DOI":"10.1111\/febs.16059","article-title":"Signaling pathways and defense mechanisms of ferroptosis","volume":"289","author":"Liu","year":"2022","journal-title":"FEBS J"},{"key":"2025063006161384000_CIT0028","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.1111\/jcmm.14511","article-title":"Molecular mechanisms of ferroptosis and its role in cancer therapy","volume":"23","author":"Xu","year":"2019","journal-title":"J Cell Mol Med"},{"key":"2025063006161384000_CIT0029","doi-asserted-by":"publisher","first-page":"659260","DOI":"10.3389\/fcell.2021.659260","article-title":"BCAT1 activates PI3K\/AKT\/mTOR pathway and contributes to the angiogenesis and tumorigenicity of gastric cancer","volume":"9","author":"Shu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2025063006161384000_CIT0030","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.humpath.2018.02.003","article-title":"Overexpression of BCAT1 is a prognostic marker in gastric cancer","volume":"75","author":"Xu","year":"2018","journal-title":"Hum Pathol"},{"key":"2025063006161384000_CIT0031","doi-asserted-by":"publisher","first-page":"107673","DOI":"10.1016\/j.isci.2023.107673","article-title":"LncRNA THUMPD3-AS1 promotes invasion and EMT in gastric cancer by regulating the miR-1297\/BCAT1 pathway","volume":"26","author":"Zhang","year":"2023","journal-title":"iScience"},{"key":"2025063006161384000_CIT0032","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1158\/2326-6066.CIR-22-0218","article-title":"DKK1 Promotes tumor immune evasion and impedes Anti-PD-1 treatment by inducing immunosuppressive macrophages in gastric cancer","volume":"10","author":"Shi","year":"2022","journal-title":"Cancer Immunol Res"},{"key":"2025063006161384000_CIT0033","doi-asserted-by":"publisher","first-page":"4756","DOI":"10.3390\/cancers15194756","article-title":"DKK1 promotes epithelial-mesenchymal transition and cisplatin resistance in gastric cancer via activation of the PI3K\/AKT pathway","volume":"15","author":"Li","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2025063006161384000_CIT0034","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1177\/030089167906500308","article-title":"Variations in serum copper and ceruloplasmin levels in advanced gastrointestinal cancer treated with polychemotherapy","volume":"65","author":"Scanni","year":"1979","journal-title":"Tumori"},{"key":"2025063006161384000_CIT0035","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.12659\/MSM.916475","article-title":"Recent Advances in the surgical treatment of advanced gastric cancer: a review","volume":"25","author":"Tan","year":"2019","journal-title":"Med Sci Monit"},{"key":"2025063006161384000_CIT0036","doi-asserted-by":"publisher","first-page":"854","DOI":"10.3390\/biology10090854","article-title":"recent updates on mechanisms of resistance to 5-fluorouracil and reversal strategies in colon cancer treatment","volume":"10","author":"Azwar","year":"2021","journal-title":"Biology (Basel)"},{"key":"2025063006161384000_CIT0037","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s11658-021-00271-y","article-title":"Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2\/Keap1\/xCT signaling","volume":"26","author":"Fu","year":"2021","journal-title":"Cell Mol Biol Lett"},{"key":"2025063006161384000_CIT0038","doi-asserted-by":"publisher","first-page":"e76451","DOI":"10.7554\/eLife.76451","article-title":"Lactate receptor HCAR1 regulates neurogenesis and microglia activation after neonatal hypoxia-ischemia","volume":"11","author":"Kennedy","year":"2022","journal-title":"Elife"},{"key":"2025063006161384000_CIT0039","doi-asserted-by":"publisher","first-page":"5301","DOI":"10.1158\/0008-5472.CAN-14-0319","article-title":"Cell surface lactate receptor GPR81 is crucial for cancer cell survival","volume":"74","author":"Roland","year":"2014","journal-title":"Cancer Res"},{"key":"2025063006161384000_CIT0040","doi-asserted-by":"publisher","first-page":"70898","DOI":"10.18632\/oncotarget.12286","article-title":"G-protein-coupled receptor 81 promotes a malignant phenotype in breast cancer through angiogenic factor secretion","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"key":"2025063006161384000_CIT0041","doi-asserted-by":"publisher","first-page":"107451","DOI":"10.1016\/j.pharmthera.2019.107451","article-title":"Lactate\/GPR81 signaling and proton motive force in cancer: Role in angiogenesis, immune escape, nutrition, and Warburg phenomenon","volume":"206","author":"Brown","year":"2020","journal-title":"Pharmacol Ther"},{"key":"2025063006161384000_CIT0042","doi-asserted-by":"publisher","first-page":"1026871","DOI":"10.3389\/fgene.2022.1026871","article-title":"Potential value of the homologous recombination deficiency signature we developed in the prognosis and drug sensitivity of gastric cancer","volume":"13","author":"Wu","year":"2022","journal-title":"Front Genet"},{"key":"2025063006161384000_CIT0043","doi-asserted-by":"publisher","first-page":"972020","DOI":"10.3389\/fcell.2022.972020","article-title":"Lactylation, an emerging hallmark of metabolic reprogramming: current progress and open challenges","volume":"10","author":"Liu","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"2025063006161384000_CIT0044","doi-asserted-by":"publisher","first-page":"6124","DOI":"10.1002\/cam4.1820","article-title":"Lactate dehydrogenase A: a key player in carcinogenesis and potential target in cancer therapy","volume":"7","author":"Feng","year":"2018","journal-title":"Cancer Med"},{"key":"2025063006161384000_CIT0045","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.tig.2021.09.009","article-title":"Histone lactylation: epigenetic mark of glycolytic switch","volume":"38","author":"Dai","year":"2022","journal-title":"Trends Genet"},{"key":"2025063006161384000_CIT0046","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3389\/fonc.2019.01143","article-title":"Lactate in the regulation of tumor microenvironment and therapeutic approaches","volume":"9","author":"de la Cruz-L\u00f3pez","year":"2019","journal-title":"Front Oncol"},{"key":"2025063006161384000_CIT0047","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/s0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"2025063006161384000_CIT0048","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41392-023-01555-9","article-title":"CDK7-YAP-LDHD axis promotes D-lactate elimination and ferroptosis defense to support cancer stem cell-like properties","volume":"8","author":"Lv","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"2025063006161384000_CIT0049","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1093\/neuonc\/noab114","article-title":"MEF2C silencing downregulates NF2 and E-cadherin and enhances Erastin-induced ferroptosis in meningioma","volume":"23","author":"Bao","year":"2021","journal-title":"Neuro Oncol"},{"key":"2025063006161384000_CIT0050","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s10753-022-01637-w","article-title":"Lactylation: a passing fad or the future of posttranslational modification","volume":"45","author":"Xin","year":"2022","journal-title":"Inflammation"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/carcin\/advance-article-pdf\/doi\/10.1093\/carcin\/bgaf030\/63449910\/bgaf030.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/carcin\/article-pdf\/46\/2\/bgaf030\/63449910\/bgaf030.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/carcin\/article-pdf\/46\/2\/bgaf030\/63449910\/bgaf030.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T06:16:17Z","timestamp":1751264177000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article\/doi\/10.1093\/carcin\/bgaf030\/8158259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4,3]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgaf030","relation":{},"ISSN":["0143-3334","1460-2180"],"issn-type":[{"value":"0143-3334","type":"print"},{"value":"1460-2180","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2025,2]]},"article-number":"bgaf030"}}